These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
371 related items for PubMed ID: 30890403
1. BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases. Zarkesh M, Zadeh-Vakili A, Akbarzadeh M, Nozhat Z, Fanaei SA, Hedayati M, Azizi F. Life Sci; 2019 Apr 15; 223():166-173. PubMed ID: 30890403 [Abstract] [Full Text] [Related]
2. BRAFV600E mutation, BRAF-activated long non-coding RNA and miR-9 expression in papillary thyroid carcinoma, and their association with clinicopathological features. Shi C, Cao J, Shi T, Liang M, Ding C, Lv Y, Zhang W, Li C, Gao W, Wu G, Man J. World J Surg Oncol; 2020 Jun 27; 18(1):145. PubMed ID: 32593310 [Abstract] [Full Text] [Related]
3. Diagnostic Value and Challenges of BRAF V600E Molecular Testing and Thyroid Fine-Needle Aspiration Cytology: A Retrospective Study from a Tertiary Institution in Southern Hunan Province, China. Lan Z, Yang F, Zhang J, Lan Y, Li H, He R. Acta Cytol; 2023 Jun 27; 67(6):629-638. PubMed ID: 37708867 [Abstract] [Full Text] [Related]
4. [Correlation between Ultrasound-guided Fine-needle Aspiration Combined with BRAF V600EDetection and Invasive Pathological Features of Papillary Thyroid Cancer]. Zhang Y, Luo YK, Zhang Y, Zhang MB, Guang Y, Xie F, Jiang B, Tang J. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Aug 30; 41(4):517-523. PubMed ID: 31484615 [Abstract] [Full Text] [Related]
5. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma. Zhao H, Zhang ZH, Zhou B, Xiao T, Pan QJ, Guo HQ. Diagn Cytopathol; 2015 Oct 30; 43(10):786-90. PubMed ID: 26152656 [Abstract] [Full Text] [Related]
8. MicroRNA-150-5p affects cell proliferation, apoptosis, and EMT by regulation of the BRAFV600E mutation in papillary thyroid cancer cells. Yan R, Yang T, Zhai H, Zhou Z, Gao L, Li Y. J Cell Biochem; 2018 Nov 30; 119(11):8763-8772. PubMed ID: 30126001 [Abstract] [Full Text] [Related]
15. Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules. Beiša A, Kvietkauskas M, Beiša V, Stoškus M, Ostanevičiūtė E, Jasiūnas E, Griškevičius L, Šeinin D, Šileikytė A, Strupas K. Exp Clin Endocrinol Diabetes; 2019 Apr 17; 127(4):247-254. PubMed ID: 29566402 [Abstract] [Full Text] [Related]
20. BRAFV600E mutation test on fine-needle aspiration specimens of thyroid nodules: Clinical correlations for 4600 patients. Chen H, Song A, Wang Y, He Y, Tong J, Di J, Li C, Zhou Z, Cai X, Zhong D, Da J. Cancer Med; 2022 Jan 17; 11(1):40-49. PubMed ID: 34851044 [Abstract] [Full Text] [Related] Page: [Next] [New Search]